Nanobiotix ADR (NBTX): Next-Year EPS Estimate 58.66%
As of 2026-06-11, Nanobiotix ADR (NBTX) has a next-year EPS growth estimate of 58.66%.
On 2026-06-04, analyst consensus for NBTX's next-year EPS growth shifted from 71.03% to 58.66% — a negative change of 12.37 percentage points. The revised estimate has been sustained across 6 subsequent trading sessions. Current-year growth is projected at 60.10%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 58.66%
- EPS growth this year
- 60.10%
- EPS next quarter (est)
- N/A
- Last price
- $35.33
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 58.66% | 60.10% | N/A | $35.33 |
| 2026-06-10 | 58.66% | 60.10% | N/A | $33.55 |
| 2026-06-09 | 58.66% | 60.10% | N/A | $34.34 |
| 2026-06-08 | 58.66% | 60.10% | N/A | $35.88 |
| 2026-06-07 | 58.66% | 60.11% | N/A | $35.46 |
| 2026-06-04 | 58.66% | 60.11% | N/A | $36.91 |
| 2026-06-03 | 71.03% | 62.75% | N/A | $35.20 |
| 2026-06-02 | 71.46% | 62.41% | N/A | $36.76 |
| 2026-06-01 | 71.46% | 62.41% | N/A | $38.00 |
| 2026-05-31 | 71.51% | 62.35% | N/A | $40.40 |
| 2026-05-28 | 71.51% | 62.35% | N/A | $40.41 |
| 2026-05-27 | 71.51% | 62.35% | N/A | $40.50 |
| 2026-05-26 | 71.51% | 62.35% | N/A | $40.80 |
| 2026-05-25 | 72.16% | 61.47% | N/A | $41.01 |
| 2026-05-24 | 72.16% | 61.47% | N/A | $41.01 |
| 2026-05-21 | 88.54% | 60.27% | N/A | $40.18 |
| 2026-05-20 | 88.51% | 60.20% | N/A | $43.16 |
| 2026-05-19 | 88.51% | 60.20% | N/A | $46.20 |
| 2026-05-18 | 88.55% | 60.07% | N/A | $49.48 |
| 2026-04-30 | 36.54% | 61.16% | N/A | $34.62 |
| 2026-04-29 | 36.54% | 61.16% | N/A | $32.99 |
| 2026-04-28 | 36.54% | 61.16% | N/A | $33.12 |
| 2026-04-27 | 36.54% | 61.16% | N/A | $33.11 |
| 2026-04-26 | 36.54% | 61.16% | N/A | $33.58 |
| 2026-04-24 | 36.54% | 61.16% | N/A | $33.58 |
| 2026-04-23 | 36.54% | 61.16% | N/A | $33.71 |
| 2026-04-22 | 36.64% | 61.10% | N/A | $32.19 |
| 2026-04-21 | 36.69% | 51.43% | N/A | $30.80 |
| 2026-04-20 | 36.69% | 51.43% | N/A | $31.91 |
| 2026-04-19 | 37.01% | 51.77% | N/A | $33.79 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Nanobiotix ADR's next-year EPS growth estimate?▾
As of 2026-06-11, Nanobiotix ADR (NBTX) has a next-year EPS growth estimate of 58.66%, based on analyst consensus.
When was the latest EPS estimate revision for NBTX?▾
The most recent revision occurred on 2026-06-04, when analysts adjusted the next-year EPS growth estimate from 71.03% to 58.66%.
What sector and industry does Nanobiotix ADR belong to?▾
Nanobiotix ADR operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NBTX appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Nanobiotix ADR (NBTX) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports